![]() ![]() Prospective results from the Québec Cardiovascular Study. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Lamarche B, Tchernof A, Moorjani S, et al. Risk factors for unplanned and crash dialysis starts: a protocol for a systematic review and meta-analysis. CKD quality improvement intervention with PCMH integration: health plan results. Vassalotti JA, DeVinney R, Lukasik S, et al. Chronic kidney disease in the United States, 2021. Through significant investments in novel technology, Cleveland HeartLab ® is fostering innovation to detect these conditions in their early stages, providing the opportunity for stage-targeted intervention and improved clinical outcomes.ġ. 10Ĭardiovascular disease (CVD) is strongly associated with type 2 diabetes (T2DM), chronic kidney disease (CKD), and nonalcoholic fatty liver disease (NAFLD). More than 75% of those who have T2DM have NAFLD.8 The leading causes of end-stage renal disease are diabetes and hypertension. Nearly 40% of persons who have diabetes and more than 30% of those who have hypertension also have CKD.Those who have T2DM have a 2 to 3 times higher risk of fatal coronary heart disease. ![]() Cardiovascular disease is the leading cause of death for individuals who have T2DM, 4 stage 4-5 CKD, 5 and NAFLD.With more people at risk for cardiovascular disease than ever before, the Quest Cardiometabolic Center of Excellence™ at Cleveland HeartLab® is advancing a prevention-focused approach for heart disease and associated metabolic conditions.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |